Automated Nucleic Acid Extraction Devices Market Overview, Analysis And Demand By 2034


Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

How Is the Automated Nucleic Acid Extraction Devices Market Growth Forecast from 2025 to 2029?
The automated nucleic acid extraction devices market size has grown rapidly in recent years. It will grow from $5.93 billion in 2024 to $6.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing demand for molecular diagnostics, growing awareness of the benefits of automation, expansion of the pharmaceutical and biotechnology industries, government initiatives to promote molecular diagnostics, growing demand for molecular diagnostics.

The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.15 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increased demand for personalized medicine, increasing demand for automation, increasing focus on precision medicine, increasing demand for point-of-care testing, integration with next-generation sequencing. Major trends in the forecast period include technological advancements, increasing demand for molecular diagnostics, miniaturization of automated systems, point-of-care testing, integration of artificial intelligence (AI) and data analytics.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp

What Are the Key Growth Factors Supporting the Automated Nucleic Acid Extraction Devices Market Expansion?
A growing number of research and development activities is expected to propel the growth of the automated nucleic acid extraction devices market going forward. Research and development activities are activities carried out by businesses to inquire about and gather market information prior to the start of the development process in order to create and introduce new goods and services to the market and increase the bottom line of the business. The automated nucleic acid extraction devices are used in research and development activities for clinical diagnosis, biological analysis, and environmental monitoring to boost companies' efforts to develop new solutions. For instance, in July 2022, according to the World Health Organization (WHO), a Switzerland-based specialized health agency of the United Nations, due to the increasing investment made by the countries during the COVID-19 pandemic, the percentage of nations equipped to conduct genomic surveillance rose from 54% to 68% between March 2021 and January 2022. Therefore, the growing number of research and development activities is driving the growth of the automated nucleic acid extraction devices market.

What Segments Are Covered in the Automated Nucleic Acid Extraction Devices Market Report?
The automated nucleic acid extraction devicesmarket covered in this report is segmented –

1) By Type: Instruments, Kits, Consumables
2) By Product: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes

Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes

How Are Current Trends Influencing the Automated Nucleic Acid Extraction Devices Market Growth?
Product innovation is a key trend gaining popularity in the market for automated nucleic acid extraction devices. Major companies operating in the automated nucleic acid extraction devices market are introducing innovative products to sustain their position in the market. For instance, in August 2022, Aurora Biomed, a Canada-based manufacturer of automated medical equipment, introduced the VERSA NAP Automated DNA Extraction Systems (also known as the automated nucleic acid extraction system) to automate DNA and RNA extractions and their related purification protocols. The system can process 1-96 samples at the same time and is capable of isolating pure, high-quality DNA or RNA with its plate grippers and transporters and gives high nucleic acid results.

Who Are the Key Players Driving the Automated Nucleic Acid Extraction Devices Market?
Major companies operating in the automated nucleic acid extraction devices market include QIAGEN NV, PerkinElmer Inc., F. Hoffmann-La Roche AG, Die Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Illumina Inc., Tecan Trading AG, Merck Co. & KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Tianlong-Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Tecan Group Ltd., Beckman CoulterInc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, BioChain Institute Inc., Biomatrica Inc., Corbett Life Science Pty Ltd., Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., LGC Biosearch Technologies, MicroGEM International Company, Norgen Biotek Corp.

Get the full automated nucleic acid extraction devices market report here:
https://www.thebusinessresearchcompany.com/report/automated-nucleic-acid-extraction-devices-global-market-report

How Does Automated Nucleic Acid Extraction Devices Market Growth Vary Across Major Regions?
North America was the largest region in the automated nucleic acid extraction devices market in 2024. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more